BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.
BET溴结构域抑制剂阻断了AR抑制、E2F1激活的治疗后出现的神经内分泌前列腺癌谱系可塑性程序
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-4968
Kim Dae-Hwan, Sun Duanchen, Storck William K, Welker Leng Katherine, Jenkins Chelsea, Coleman Daniel J, Sampson David, Guan Xiangnan, Kumaraswamy Anbarasu, Rodansky Eva S, Urrutia Joshua A, Schwartzman Jacob A, Zhang Chao, Beltran Himisha, Labrecque Mark P, Morrissey Colm, Lucas Jared M, Coleman Ilsa M, Nelson Peter S, Corey Eva, Handelman Samuel K, Sexton Jonathan Z, Aggarwal Rahul, Abida Wassim, Feng Felix Y, Small Eric J, Spratt Daniel E, Bankhead Armand 3rd, Rao Arvind, Gesner Emily M, Attwell Sarah, Lakhotia Sanjay, Campeau Eric, Yates Joel A, Xia Zheng, Alumkal Joshi J
